Strategikon Pharma Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Strategikon Pharma's estimated annual revenue is currently $4.5M per year.(i)
  • Strategikon Pharma's estimated revenue per employee is $155,000

Employee Data

  • Strategikon Pharma has 29 Employees.(i)
  • Strategikon Pharma grew their employee count by 21% last year.

Strategikon Pharma's People

NameTitleEmail/Phone
1
VP Business DevelopmentReveal Email/Phone
2
Head Software DevelopmentReveal Email/Phone
3
SVP, Marketing and Investor RelationsReveal Email/Phone
4
Business Development AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Strategikon Pharma?

Clinical Maestro™ is an end-to-end elegant cloud-based platform to more efficiently budget, source and manage complex clinical programs. We believe that intuitive technology, complete transparency and effective communication between biopharmaceutical companies and providers will revolutionize the productivity of clinical research. Clinical Maestro™: New Ways to Solve Old Problems. Our name – Strategikon Pharma – comes from a famous strategy manual written by the Byzantine emperor Maurice. The world of clinical trials is certainly different, but the principles of defining and executing flexible strategies that are well matched to the challenges, still applies today. As Maurice put it: A leader should never have to say: ‘I did not expect it.'

keywords:N/A

N/A

Total Funding

29

Number of Employees

$4.5M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M29-9%N/A
#2
$4.6M290%N/A
#3
$4.5M29-40%N/A
#4
$4.3M294%N/A
#5
$2.5M310%N/A